Buscar
Mostrando ítems 1-10 de 462
Harmonization of Pharmacovigilance Regulation in Brazil: Opportunities to Improve Risk Communication
(Elsevier B.V., 2019-03-01)
Brazilian pharmacovigilance regulations involve 3 spheres: health services, Marketing Authorization Holders (MAHs), and sanitary agency. Drug tolerability began to be effectively assessed in Brazil after the founding of ...
Pharmacovigilance of Biopharmaceuticals in Rheumatic Diseases, Adverse Events, Evolution, and Perspective: An Overview
(Biomedicines, 2020-08-23)
Since we have gained an understanding of the immunological pathophysiology of rheumatic diseases such as rheumatoid arthritis and systemic lupus erythematosus, treatment based on biological drugs has become a fundamental ...
Patient Organizations’ Barriers in Pharmacovigilance and Strategies to Stimulate Their Participation
(2020)
European drug regulations aim for a patient-centered approach, including involving patients in the pharmacovigilance (PV) systems. However many patient organizations have little experience on how they can participate in ...
Pharmacovigilance of biotechnological therapies: how Bio-Manguinhos has been preparing itself for the challenges that have arisen?
(Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2018)
Situational strategic planning of the pharmacovigilance of Covid-19 vaccine (ChAdOx1-S [recombinant]) at Bio-Manguinhos/Fiocruz
(Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2021)
Effectiveness of pharmacovigilance: Multifaceted educational intervention related to the knowledge, skills and attitudes of multidisciplinary hospital staff
(2017-01-01)
OBJECTIVES: Most educational interventions in pharmacovigilance are designed to encourage physicians to report adverse drug reactions. However, multidisciplinary teams may play an important role in reporting drugrelated ...
Regulatory issues on pharmacovigilance in Latin American countries
(Network of Centres for Study of Pharmaceutical Law, 2014)
Pharmacovigilance is responsible for monitoring the safety of medicines in normal clinical use andduring clinical trials. Legal requirements for pharmacovigilance in some Latin American countries (Argentina, Brazil, Chile, ...
Pharmacovigilance of Herbal Medicines the Potential Contributions of Ethnobotanical and Ethnopharmacological Studies
(Adis Int Ltd, 2013-01-01)
Typically, ethnobotanical/ethnopharmacological (EB/EP) surveys are used to describe uses, doses/dosages, sources and methods of preparation of traditional herbal medicines; their application to date in examining the adverse ...